Birgit Corinna Schultes

This inventor holds 8 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Quest Pharmatech, Inc., Altarex Medical Corp., Momenta Pharmaceuticals, Inc.. Active years: 2004-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Birgit Corinna Schultes. Retrieved from https://idiyas.com/inventor/birgit-corinna-schultes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 13)

% Patents Active = 87.5

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 14(Granted Patents)

Company Filing History:

3 out of 10

Quest Pharmatech, Inc.

patents

2 out of 4

Altarex Medical Corp.

patents

2 out of 121

Momenta Pharmaceuticals, Inc.

University of California

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391759 - Methods related to engineered Fc constructs (2025-08-19),

2. 11661456 - Sialylated glycoproteins (2023-05-30),

3. 8945566 - Methods for improving the bioactivity of therapeutic IgE antibodies for the treatment of disease (2015-02-03),

4. 8697079 - IgE antibodies for the treatment of cancer (2014-04-15),

5. 8038994 - Combination therapy for treating disease (2011-10-18),

6. 7579445 - Reagents and methods for inducing an immune response to prostate specific antigen (2009-08-25),

7. 7318921 - Therapeutic compositions that alter the immune response (2008-01-15),

8. 6689355 - Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells (2004-02-10),

Title: The Innovative Contributions of Birgit Corinna Schultes

Introduction

Birgit Corinna Schultes is a prominent inventor based in Arlington, MA, known for her significant contributions to the field of biotechnology. With a total of eight patents to her name, she has made remarkable advancements in therapeutic constructs and pharmaceutical preparations.

Latest Patents

Among her latest patents, one focuses on methods related to engineered Fc constructs. This invention pertains to the use of biologically active Fc domain-containing therapeutic constructs to induce immune cell activation, which can be pivotal in treating diseases such as cancers and infections. Another notable patent involves sialylated glycoproteins, which describes pharmaceutical preparations containing polypeptides with specific sialylation patterns. These preparations are aimed at treating immune-related thrombocytopenia.

Career Highlights

Throughout her career, Birgit has worked with esteemed companies such as Quest Pharmatech, Inc. and Momenta Pharmaceuticals, Inc. Her work has been instrumental in advancing therapeutic solutions in the pharmaceutical industry.

Collaborations

Birgit has collaborated with notable professionals in her field, including Antoine A Noujaim and Christopher F Nicodemus. These collaborations have further enriched her research and innovations.

Conclusion

Birgit Corinna Schultes exemplifies the spirit of innovation in biotechnology through her patents and collaborations. Her work continues to impact the medical field positively, showcasing the importance of inventive contributions in addressing complex health challenges.

Profile summary based on public USPTO records.